References
- Roy D J. Palliative Care Canada: A question period. J Palliat Care 1999; 15(1)3–5
- Sathyamala Bhanot N. Nirmalasundaram How did doctors of modern medicine come to exercise complete control over all matters related to ill health?-Taking
- Moore M. Stupid White Men. Reagan Books, Harper Collins, New York 2001
- Mittra I. Fight against Cancer in countries with limited resources. European Journal of Cancer 1997; 33(4)511
- Ferriman A. I billion dollar drug deal creates debt for tomorrow's AIDS orphans. BMJ 2000; 321: 784
- Allan K. Health promoting palliative care, 1999. Mortality 1999; 4(1)75–82
- Sidley P. South Africa to tighten control on drug trials after five deaths. BMJ 2000; 15(4)1028
- Maria A. Investigators responsibilities for human subjects in developing countries. New Engl J Med 2000; 342: 921–9
- Freemann H P, Payne R. Racial injustice in health Care. New Engl J Med 2000; 342: 1094–1100
- Peay M Y, Peay E R. The role of commercial sources in the adoption of a new drug. Soc Sci Med 1988; 26: 1183
- Avon J, Chen M, Hartley R. Science v/s commercial sources of influence on physician's behavior. Amer J Med 1982; 73: 4–8
- Day R. How to make the most of a visit from a pharmaceutical company representative. Australian Prescriber 2000; 23(5)97
- Bruera E, Ripamonti C, Beattie-Palmer L. Use of trade names of drugs in abstracts from pain congresses. New Engl J Med 2000; 343(11)818
- Steinmann M A, Shlipak M G, McPhee S J. Of principles and pens. Attitudes and practices of medicine house staff towards pharmaceutical industry promotions. Amer J Med 2001; 110(7)551–7
- America's largest Corporations. Fortune 500, Fortune annual special edition. 2002, Families USA: where drug dollars go?
- Brian N. Culture, palliative care. International Journal of Palliative Nursing 2002; 18(5)240–246
- Sternsward J, Pampallona S. Palliative medicine-A Global Perspective. Oxford text book of Palliative Medicine, G Hanks, et al. Oxford University Press, NY 1988